The Microbiome’s Role in Gastrointestinal Cancers
Time: 9:00 am
day: Conference Day Two, 7:30 - 10:00
Details:
- Exploring the Microbiome & Colorectal Cancer: How gut microbiota modulate colorectal cancer risk and progression, evaluating the influence of microbial metabolites (e.g., butyrate) on tumor microenvironment and elucidating microbiome interactions with immunotherapy and chemotherapy response
- Other GI Cancers (Pancreatic, Gastric & Esophageal): exploring key microbiome-driven mechanisms in upper GI cancers, the role of bacterial dysbiosis in inflammation and tumorigenesis, and exploring current and emerging microbiome-targeted therapeutic strategies
- Translating Microbiome Research into Oncology Practice: including strategies for microbiome modulation, the potential for microbiome-based biomarkers in GI cancer detection and challenges and future directions in integrating microbiome science into cancer care
